American Society of Hirudotherapy

Chronic Venous Insufficiency (CEAP C3-C5)

Off-label adjunct to compression; the journal evidence is one small open-label randomized trial in varicose veins (n=50) and a 20-patient uncontrolled series; the books describe further reports (see “What the books describe” below).

Tier B — RCT-supported off-labelStudied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for chronic venous insufficiency has been examined in only a few small studies and is not FDA-evaluated.
What evidence exists?
Published evidence is small. One open-label randomized trial of 50 patients with varicose veins (Nigar 2011) reported less pain, limb swelling and skin pigmentation in the leech group, while the compression-stocking group improved in pain and swelling but not pigmentation; a 20-patient uncontrolled series (Bapat 1998) reported similar changes. Both were small, and the trial was not blinded. Two medical books, by Baskova and Isakhanyan and by Michalsen and colleagues, describe further reports and clinical experience (see “What the books describe” below). Effects are symptomatic only; the abnormal veins themselves are not removed. Compression therapy remains the first-line standard. Leech therapy is an adjunct, not a replacement for compression stockings, lifestyle changes, or procedures such as vein ablation when indicated.
Main risks
  • Bleeding and oozing from each bite site for hours to a full day
  • Mild anemia if many leeches are used across multiple sessions (rarely requires transfusion)
  • Itching, redness, and irritation at the bite sites lasting days to weeks
  • Bruising along the treated leg
  • Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
  • Allergic reaction to leech saliva (uncommon)
  • Skin pigmentation changes or small permanent scars at the bite sites
Who should not consider this
  • Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
  • Patients with hemophilia or other inherited bleeding disorders
  • Patients with anemia
  • Patients with a weakened immune system, especially severe neutropenia
  • Patients with active deep vein thrombosis (within the last 2 weeks)
  • Patients with critical limb ischemia (severe artery disease in the leg)
  • Patients with an open leg ulcer that is infected with surrounding cellulitis
What to ask your clinician
  • What is my CEAP stage, and have I been seen by a vein specialist?
  • Have I given compression stockings a fair trial (proper fit, daily use, several months)?
  • Should I consider procedures such as vein ablation, sclerotherapy, or stripping before or instead of leech therapy?
  • What is the realistic symptom benefit I can expect from leech therapy, and for how long?
  • What is the practitioner's training, supplier, and Aeromonas prevention protocol?
  • How will my blood count be monitored across multiple sessions?
  • What is the cost, and is it covered by insurance? (typically not)
When to seek urgent care
  • Bleeding from a bite site lasting more than 24 to 48 hours, or soaking through dressings
  • New unilateral leg swelling, pain, or warmth (possible deep vein thrombosis)
  • Spreading redness, warmth, pus, or red streaks (cellulitis or infection)
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, facial swelling, throat tightness, or breathing difficulty

What this does NOT mean

  • It does not mean leech therapy is FDA-cleared for venous insufficiency — it is not.
  • It does not mean varicose veins disappear — they remain; the treatment is symptomatic only.
  • It does not mean you can stop wearing compression stockings — compression is still the foundation of care.
  • It does not mean leech therapy replaces vein procedures such as ablation when those are medically indicated.
  • It does not mean improvement is permanent — symptoms typically return without ongoing compression and lifestyle measures.

Clinical Profile

Category
Vascular
ICD-10
I87.2, I87.31, I87.32, I87.33
Safety tier
Medium

Evidence Summary

No trial of leech therapy has staged patients by CEAP class, and the clinical literature on varicose veins and their complications is small. One open-label randomized trial (Nigar 2011, n=50) compared leech therapy with grade 2 compression stockings plus limb elevation: the leech group had reductions in pain, limb girth, pigmentation and incompetent perforators, while the stocking group improved in pain and limb girth but not pigmentation, and saphenofemoral and saphenopopliteal incompetence did not improve in either group. A prospective uncontrolled series of 20 patients with complicated varicose veins (Bapat 1998) reported less edema and limb girth, and a single-centre series (Farzali 2025) reported the lowest success rate of its 11 conditions for varicose veins (33%, n=30). The 2004 monograph by Baskova and Isakhanyan additionally summarizes further reports in postphlebitic syndrome and acute thrombophlebitis of the lower limbs, and Michalsen et al. (2007) describe their clinical experience with varicose veins (see “What the books describe” below). The proposed rationale is that leeches transiently relieve local venous hypertension via bite-site oozing and salivary anticoagulant action, so any effect would be symptomatic rather than anatomic: varicose veins persist. Compression therapy remains the first-line standard, and leech therapy is at most an investigational adjunct when compression alone is inadequate.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan list diseases of the leg veins — varicose veins, thrombophlebitis, postphlebitic syndrome, varicose ulcers — among the indications for hirudotherapy[B1].
  • They retell the observations of Eldor and colleagues (1998) in 87 patients with postphlebitic syndrome: as they describe it, after leeches the pain and heaviness in the legs decreased and blood circulation in the skin improved; the effect appeared almost immediately and lasted three weeks[B1].
  • Michalsen et al. write that leeches do not eliminate the venous dilatation and valvular insufficiency, but in most cases noticeably reduce swelling, pain and the feeling of heaviness in the area of the varicose veins; they stress that leeches should be used together with other effective methods, above all those that relieve venous congestion[B3].
  • Baskova and Isakhanyan call deep vein thrombosis potentially life-threatening: the clot can break off and block branches of the pulmonary artery[B1].
  • Michalsen et al. consider that using leeches as supportive treatment for acute deep vein thrombosis of the legs cannot be justified: blood-thinning medicines at the start of treatment are a contraindication to leeches; in postphlebitic syndrome, leeches can be applied as a superficial supportive treatment only after such therapy has ended[B3].
  • They also advise against performing hirudotherapy on hot days unless absolutely necessary, and never placing leeches directly on skin with marked inflammation (dermatitis) or ulceration[B3].
  • Michalsen et al. advise warning patients in advance that hirudotherapy relieves symptoms but does not change the appearance of varicose veins[B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Active deep vein thrombosis (acute phase)
  • Critical limb ischemia (ABI <0.4)
  • Active venous ulceration with surrounding cellulitis

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.